CLS-TA (suprachoroidal topicalized triamcinolone acetonide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CLS-TA (suprachoroidal topicalized triamcinolone acetonide), covering 2021-05-13 to 2021-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema [Phase 2]